Bortezomib in refractory ANCA-associated vasculitis: a new option?

Novikov, Pavel; Moiseev, Sergey; Bulanov, Nikolay; Shchegoleva, Elena

Novikov, Pavel; Moiseev, Sergey; Bulanov, Nikolay; Shchegoleva, Elena.

Novikov P; Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
Moiseev S; Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
Bulanov N; Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
Shchegoleva E; Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.

Ann Rheum Dis ; 75(1): e9, 2016 Jan.

Article en En | MEDLINE | ID: mdl-26199397

Asunto(s)

Ácidos Borónicos/farmacología; Ácidos Borónicos/uso terapéutico; Lupus Eritematoso Sistémico/tratamiento farmacológico; Células Plasmáticas/efectos de los fármacos; Inhibidores de Proteasoma/farmacología; Inhibidores de Proteasoma/uso terapéutico; Pirazinas/farmacología; Pirazinas/uso terapéutico; Femenino; Humanos; Masculino

Palabras clave

Systemic Lupus Erythematosus; Systemic vasculitis; Treatment

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Pirazinas / Ácidos Borónicos / Inhibidores de Proteasoma / Lupus Eritematoso Sistémico Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google